Recruiting NCT07077473

Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases

— Observational Familial Mediterranean Fever (FMF )

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: The protocol lists: real word drugs.
Who it may be relevant to: Registry conditions: Familial Mediterranean Fever (FMF ). Basic parameters: No limits · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: China
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Official title

A Retrospective Study Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases

retrospective observe the efficacy and safety of different drugs used in familial Mediterranean fever (FMF) cases in real-world

Clinical responses graded as Patient Global Assessment (PGA ) decrease [Time frame: From baseline,4, 8, 12, 24 and week 52]

\- Clinical diagnosis of Familial Mediterranean fever (FMF) patients (Tel Hashomer criteria)

Have a history of mental illness, or alcohol and drug dependence；
Pregnant, with severe infection, severe cardiac insufficiency, severe liver or kidney dysfunction；
Complicated with tumors, organ transplants, etc. which have significant impact on the immune system or require the use of immunosuppressants.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

China · 1 center

NCT: NCT07077473 · TJ-IRB202412016